Ascendis Pharma A/S (ASND) Q1 2015 Earnings Results

Ascendis Pharma A/S Beats on EPS, Stock Up 1.68%

Ascendis Pharma reported a positive surprise in earnings per share, significantly exceeding expectations. However, there was no revenue reported, which leaves some uncertainty about the company's overall performance. The stock reacted positively, increasing by 1.68%, likely driven by the strong EPS figure despite the lack of revenue details.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.07	N/A	+117.40%
Revenue	—	N/A	—

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Ascendis Pharma A/S Beats on EPS, Stock Up 1.68%

Key numbers

Management commentary

Ascendis Pharma A/S

More earnings this week

Ascendis Pharma A/S Beats on EPS, Stock Up 1.68%

Key numbers

Management commentary